Skip to main navigation
  • Home
  • About Us
    • Our Story
    • Management
    • Board of Directors
    • Advisors
  • Our Science
    • Platform Technology
    • Publications
  • Our Products
    • Toca 511 & Toca FC
    • Toca 521
    • Product Pipeline
  • Healthcare Professionals
    • Professional Resources
    • Clinical Trials
      • Toca 5 Clinical Trial
      • Toca 6 Clinical Trial
      • Toca 8 Clinical Trial
      • NRG-BN006 Clinical Trial
    • Expanded Access Program
    • Investigator Sponsored Trial
  • Patients
    • Patient Stories
    • Patient Journey
    • Education
      • Glioblastoma
      • Anaplastic Astrocytoma
      • Treatments for Brain Cancer
      • Types of Brain Cancer
      • Brain Cancer Statistics
    • Blog
    • Clinical Trials – Learn More
  • Investors
    • Stock Information
      • Stock Quote
      • Stock Chart
    • News & Events
      • Press Releases
      • Investor Calendar
      • Presentations
    • Analyst Coverage
    • Financials
      • SEC Filings
      • Financial Reports
      • Quarterly Results
    • Corporate Governance
      • Documents & Charters
      • Management
      • Board of Directors
      • Committee Composition
    • Shareholder Services
      • Investor FAQ
      • Information Request
      • E-mail Alerts
  • Careers
  • Contact
Tocagen
  • Home
  • About Us
    • Our Story
    • Management
    • Board of Directors
    • Advisors
  • Our Science
    • Platform Technology
    • Publications
  • Our Products
    • Pipeline
    • Toca 511 & Toca FC
  • Healthcare Professionals
    • Professional Resources
    • Clinical Trials
      • Toca 5 Clinical Trial
      • Toca 6 Clinical Trial
      • Toca 8 Clinical Trial
      • NRG-BN006 Clinical Trial
    • Expanded Access Program
    • Investigator Sponsored Trial
  • Patients
    • Patient Stories
    • Patient Journey
    • Education
      • Glioblastoma
      • Anaplastic Astrocytoma
      • Treatments for Brain Cancer
      • Types of Brain Cancer
      • Brain Cancer Statistics
    • Blog
    • Clinical Trials – Learn More
  • Investors
    • Stock Information
      • Stock Quote
      • Stock Chart
    • News & Events
      • Press Releases
      • Investor Calendar
    • Presentations
    • Analyst Coverage
    • Financials
      • SEC Filings
      • Annual Report
      • Quarterly Results
    • Corporate Governance
      • Documents & Charters
      • Management
      • Board of Directors
      • Committee Composition
    • Shareholder Services
      • Investor FAQ
      • Information Request
      • E-mail Alerts
  • Careers
    • For Recruiters / Agencies
  • Contact

Home/ Investors/ 10-K
  • Stock Information
  • Press Releases
  • Events & Presentations
  • Analyst Coverage
  • Publications
  • SEC Filings and Financials
  • Corporate Governance
  • Shareholder Services

Tools

Print Page Print Page
RSS Feeds RSS Feeds
E-mail Alerts
IR Contacts IR Contacts

SEC Filing Details

Document Details

Form
10-K
Filing Date
Mar 9, 2018
Document Date
Dec 31, 2017
Form Description
Annual report which provides a comprehensive overview of the company for the past year
Filing Group
Annual Filings
Company
Tocagen
Issuer
Tocagen Inc

Filing Formats

View HTML
Download PDF
Download DOC
Download XLS

XBRL

XBRL Viewer
EX-101.INS - XBRL INSTANCE DOCUMENT
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
EX-101.CAL - XBRL TAXONOMY EXTENSION CALCULATION LINKBASE
EX-101.DEF - XBRL TAXONOMY EXTENSION DEFINITION LINKBASE
EX-101.LAB - XBRL TAXONOMY EXTENSION LABEL LINKBASE
EX-101.PRE - XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
2019 © Tocagen | Privacy Policy | Terms of Use
  • Facebook
  • Twitter
  • Youtube
  • Linkedin
Scroll to top